Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran for Widespread Pain in RA
NCT01207453Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of milnacipran in rheumatoid arthritis (RA), sponsored by Brigham and Women's Hospital. Started Jan 2011; status: completed.
02
Drugs
milnacipran
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01207453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01207453.